DCOY Decoy Therapeutics Inc.
Healthcare$7.30+13.53%ClosedMarket Cap: $3.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.91
P/S
0.00
EV/EBITDA
0.30
DCF Value
$20.40
FCF Yield
-168.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-395.4%
ROA
-154.7%
ROIC
-339.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-2.3M | $-2.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-9.0M | $-9.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-12.6M | $-12.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-895.1K | $-873.5K | $— | — |
| Q2 null | $0.00 | NaN% | $-965.6K | $-957.8K | $— | — |
| Q1 null | $0.00 | NaN% | $-1.7M | $-1.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.5M | $-1.5M | $— | — |
| FY null | $0.00 | NaN% | $-5.7M | $-5.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.0M | $-972.1K | $— | — |
| Q2 null | $0.00 | NaN% | $-1.5M | $-1.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.8M | $-1.7M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-970.7K | $-881.8K | $-26.73 | — |